MIMIX Trademark

Trademark Overview

On Monday, May 6, 2024, a trademark application was filed for MIMIX with the United States Patent and Trademark Office. The USPTO has given the MIMIX trademark a serial number of 98536299. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, November 25, 2024. This trademark is owned by Vaxess Technologies, Inc.. The MIMIX trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents in the form of patches, polymers, and resorbable microneedles that provide transdermal delivery of a wide range of pharmaceuticals, and applicators therefor; drug delivery agents in the form of patches, polymers, and resorbable microneedles that provide transdermal delivery of pharmaceuticals, namely, vaccines, anti-viral therapies, immunotherapies, hormones for medical purposes, treatments for obesity, cardio-metabolic diseases, pain, cough, colds, allergies, autoimmune diseases, dermatological diseases and disorders, fertility diseases, and applicators therefor; patches, polymers, and resorbable microneedles that provide transdermal delivery of vitamins and nutritional supplements, and applicators therefor
mimix

General Information

Serial Number98536299
Word MarkMIMIX
Filing DateMonday, May 6, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, November 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesDrug delivery agents in the form of patches, polymers, and resorbable microneedles that provide transdermal delivery of a wide range of pharmaceuticals, and applicators therefor; drug delivery agents in the form of patches, polymers, and resorbable microneedles that provide transdermal delivery of pharmaceuticals, namely, vaccines, anti-viral therapies, immunotherapies, hormones for medical purposes, treatments for obesity, cardio-metabolic diseases, pain, cough, colds, allergies, autoimmune diseases, dermatological diseases and disorders, fertility diseases, and applicators therefor; patches, polymers, and resorbable microneedles that provide transdermal delivery of vitamins and nutritional supplements, and applicators therefor
Pseudo MarkMI MIX; MIMICS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 6, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVaxess Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, May 6, 2024NEW APPLICATION ENTERED
Wednesday, November 20, 2024ASSIGNED TO EXAMINER
Monday, November 25, 2024NON-FINAL ACTION E-MAILED
Monday, November 25, 2024NON-FINAL ACTION WRITTEN
Monday, November 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 10, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, January 10, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, May 6, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

mimix delivery diseases provide transdermal therefor microneedles polymers patches applicators resorbable